Manulife (Manufacturers Life Insurance)
ALNY icon

Manulife (Manufacturers Life Insurance)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$219M Buy
662,365
+598,953
+945% +$204M 0.19% 120
2025
Q4 		$25.2M Sell
63,412
-4,260
-6% -$1.89M 0.02% 584
2025
Q3 		$30.9M Sell
67,672
-19,168
-22% -$7.81M 0.03% 517
2025
Q2 		$28.3M Sell
86,840
-12,029
-12% -$3.33M 0.03% 522
2025
Q1 		$26.7M Sell
98,869
-10,233
-9% -$2.63M 0.03% 522
2024
Q4 		$25.7M Sell
109,102
-82,280
-43% -$21.6M 0.02% 561
2024
Q3 		$52.6M Sell
191,382
-137,655
-42% -$35.8M 0.05% 344
2024
Q2 		$80M Sell
329,037
-7,988
-2% -$1.26M 0.07% 248
2024
Q1 		$50.4M Sell
337,025
-3,795
-1% -$633K 0.05% 332
2023
Q4 		$65.2M Sell
340,820
-15,043
-4% -$2.56M 0.04% 287
2023
Q3 		$63M Buy
355,863
+29,209
+9% +$5.57M 0.04% 281
2023
Q2 		$62M Sell
326,654
-10,874
-3% -$2.16M 0.03% 285
2023
Q1 		$67.6M Sell
337,528
-5,692
-2% -$1.2M 0.04% 278
2022
Q4 		$81.6M Sell
343,220
-567,340
-62% -$121M 0.05% 233
2022
Q3 		$183M Sell
910,560
-745,275
-45% -$142M 0.13% 125
2022
Q2 		$241M Sell
1,655,835
-95,228
-5% -$13.5M 0.17% 106
2022
Q1 		$286M Buy
1,751,063
+48,393
+3% +$7.37M 0.19% 100
2021
Q4 		$289K Sell
1,702,670
-28,763
-2% -$5.35M 0.18% 99
2021
Q3 		$327M Sell
1,731,433
-24,375
-1% -$4.57M 0.27% 89
2021
Q2 		$298M Buy
1,755,808
+150,950
+9% +$22.1M 0.24% 95
2021
Q1 		$227M Buy
1,604,858
+140,769
+10% +$21.2M 0.2% 122
2020
Q4 		$190M Buy
1,464,089
+301,315
+26% +$40.2M 0.18% 140
2020
Q3 		$169M Sell
1,162,774
-59,658
-5% -$8.48M 0.17% 132
2020
Q2 		$181M Sell
1,222,432
-57,222
-4% -$7.71M 0.17% 122
2020
Q1 		$139M Buy
1,279,654
+1,052,417
+463% +$121M 0.15% 140
2019
Q4 		$26.2M Sell
227,237
-7,612
-3% -$759K 0.03% 475
2019
Q3 		$19M Sell
234,849
-4,817
-2% -$381K 0.02% 568
2019
Q2 		$17.4M Buy
239,666
+31,429
+15% +$2.41M 0.02% 602
2019
Q1 		$19.5M Sell
208,237
-6,254
-3% -$523K 0.02% 556
2018
Q4 		$15.6M Buy
214,491
+1,426
+0.7% +$110K 0.02% 580
2018
Q3 		$18.6M Buy
213,065
+209,846
+6,519% +$21.1M 0.02% 599
2018
Q2 		$317K Sell
3,219
-21
-0.6% -$2.08K ﹤0.01% 2735
2018
Q1 		$386K Buy
3,240
+75
+2% +$9.67K ﹤0.01% 2506
2017
Q4 		$402K Buy
3,165
+340
+12% +$42.7K ﹤0.01% 2472
2017
Q3 		$332K Buy
2,825
+284
+11% +$24.2K ﹤0.01% 2575
2017
Q2 		$203K Buy
2,541
+167
+7% +$10.7K ﹤0.01% 2992
2017
Q1 		$122K Hold
2,374
– – ﹤0.01% 3102
2016
Q4 		$89K Sell
2,374
-557
-19% -$23.3K ﹤0.01% 3277
2016
Q3 		$199K Hold
2,931
– – ﹤0.01% 2777
2016
Q2 		$163K Buy
2,931
+37
+1% +$2.33K ﹤0.01% 2879
2016
Q1 		$171K Buy
2,894
+60
+2% +$3.99K ﹤0.01% 2707
2015
Q4 		$267 Hold
2,834
– – ﹤0.01% 2438
2015
Q3 		$228 Buy
2,834
+33
+1% +$3.67K ﹤0.01% 2537
2015
Q2 		$336 Buy
2,801
+627
+29% +$74.9K ﹤0.01% 2413
2015
Q1 		$227 Hold
2,174
– – ﹤0.01% 2639
2014
Q4 		$211 Sell
2,174
-27,508
-93% -$2.55M ﹤0.01% 2599
2014
Q3 		$2.32K Sell
29,682
-8,952
-23% -$577K ﹤0.01% 1282
2014
Q2 		$2.44M Sell
38,634
-116,289
-75% -$6.91M ﹤0.01% 1280
2014
Q1 		$10.4K Sell
154,923
-234
-0.2% -$18.1K 0.02% 646
2013
Q4 		$9.98K Buy
155,157
+4,678
+3% +$279K 0.02% 658
2013
Q3 		$9.63K Buy
150,479
+105,589
+235% +$5.26M 0.02% 650
2013
Q2 		$1.39M Buy
+44,890
New +$1.19M ﹤0.01% 1335

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ALNY Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its Alnylam Pharmaceuticals (ALNY) stake by 945% in Q1 2026, buying an estimated $204M and bringing the position to 662,365 shares worth $219M. The position accounts for 0.19% of the portfolio, ranked #120.

Manulife (Manufacturers Life Insurance) first reported a position in ALNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $327M in Q3 2021. 789 funds tracked by Wall St. Rank hold ALNY as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 662,365 shares of Alnylam Pharmaceuticals worth $219M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 598,953 Alnylam Pharmaceuticals shares in Q1 2026, an estimated $204M.
  • Alnylam Pharmaceuticals made up 0.19% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #120 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Alnylam Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Alnylam Pharmaceuticals position peaked at $327M in Q3 2021.
  • 789 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.